1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Hunting for Protein Markers of Hypoxia by Combining Plasma Membrane Enrichment with a New Approach to Membrane Protein Analysis
(
- Contribution to journal › Article
- 2010
-
Mark
MYCN-regulated microRNAs repress estrogen receptor-{alpha} (ESR1) expression and neuronal differentiation in human neuroblastoma.
(
- Contribution to journal › Article
- 2009
-
Mark
HIF-1{alpha} and HIF-2{alpha} Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1{alpha} Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization.
(
- Contribution to journal › Article
-
Mark
HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
(
- Contribution to journal › Article
-
Mark
HIF-2 alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
(
- Contribution to journal › Article
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
(
- Contribution to journal › Article
-
Mark
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma.
(
- Contribution to journal › Article
-
Mark
Transcriptional adaptation of neuroblastoma cells to hypoxia.
(
- Contribution to journal › Article
- 2007
-
Mark
Hypoxia inducible factor-2alpha in cancer.
(
- Contribution to journal › Article